Knowledge hub

Knowledge hub
Blog

Leveraging biomarkers to bring the right treatment to the right patient

Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
Fishing out hypotheses from a sea of data: how Ardigen’s AIKE helps scientists ask better questions
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design
Understanding microbial proteins with deep learning – part 2
Understanding microbial proteins with deep learning – part 1
Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
We are ready to support your efforts in the fight against COVID-19
Blog

Safety considerations for COVID-19 vaccines and antibody-based therapies

The microbiome as a potential weapon against novel coronavirus SARS-CoV-2
Ardigen at AI Powered Drug Discovery and Manufacturing Conference
A new publication about molecule property prediction: Molecule Attention Transformer
A new report about the use of medical data to develop AI in Poland
Ardigen at PMWC 2020
New microbiome and phenotype data from observational study will enlarge unique Ardigen’s database
New collaborations with hospitals in the area of clinical studies and data collection – press release
Ardigen’s POSTERS at the Society for Immunotherapy of Cancer’s ( SITC2019 ) Annual Meeting
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94